• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病与肠道微生物群:一种潜在联系

COVID-19 and Gut Microbiota: A Potential Connection.

作者信息

Rajput Swati, Paliwal Deepanshu, Naithani Manisha, Kothari Aashish, Meena Kiran, Rana Satyavati

机构信息

Department of Biochemistry, AIIMS Rishikesh, Uttarakhand, 249203 India.

Department of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand India.

出版信息

Indian J Clin Biochem. 2021 Jul;36(3):266-277. doi: 10.1007/s12291-020-00948-9. Epub 2021 Jan 21.

DOI:10.1007/s12291-020-00948-9
PMID:33495676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7818076/
Abstract

Currently, world is facing a global outbreak causing a pandemic threat known as COVID-19. This infectious disease is triggered by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Gut microbiota harbours multi species community with a strong impact on host immune homeostasis. However, our knowledge about this gut microbiota and its symbiotic relationship with immune activation in association with SARS-CoV-2 is limited. Unbalanced bacterial flora with too many opportunistic infections can shift immune system towards a cascade of inflammatory responses leading to multi organ damage. This review will highlight immune-regulation via various mechanisms in SARS-CoV-2 infection. Diet has an unbelievable influence on gut microbiome that allows a new state of homeostasis to be reached through timing, frequency and duration of intake. This review article focuses on gut, lung microbiota and immunomodulation with specific attention on immune activation by gut microbiota.

摘要

当前,世界正面临一场全球性疫情,引发了一种名为COVID-19的大流行威胁。这种传染病是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的。肠道微生物群包含多种菌群,对宿主免疫稳态有重大影响。然而,我们对这种肠道微生物群及其与SARS-CoV-2相关的免疫激活的共生关系的了解有限。细菌菌群失衡,机会性感染过多,会使免疫系统转向一系列炎症反应,导致多器官损伤。本综述将重点介绍SARS-CoV-2感染中通过各种机制进行的免疫调节。饮食对肠道微生物群有着不可思议的影响,通过摄入的时间、频率和持续时间可以达到一种新的稳态。这篇综述文章重点关注肠道、肺部微生物群以及免疫调节,特别关注肠道微生物群引起的免疫激活。

相似文献

1
COVID-19 and Gut Microbiota: A Potential Connection.2019冠状病毒病与肠道微生物群:一种潜在联系
Indian J Clin Biochem. 2021 Jul;36(3):266-277. doi: 10.1007/s12291-020-00948-9. Epub 2021 Jan 21.
2
The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.肠道微生物群与 COVID-19 进展的关系:对免疫发病机制和治疗的新认识。
Front Immunol. 2023 May 2;14:1180336. doi: 10.3389/fimmu.2023.1180336. eCollection 2023.
3
Roles of the gut microbiota in severe SARS-CoV-2 infection.肠道微生物群在严重 SARS-CoV-2 感染中的作用。
Cytokine Growth Factor Rev. 2022 Feb;63:98-107. doi: 10.1016/j.cytogfr.2022.01.007. Epub 2022 Jan 31.
4
Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota.饮食调节的肠道微生物群对 SARS-CoV-2 感染的调控。
Front Cell Infect Microbiol. 2023 Jun 29;13:1167827. doi: 10.3389/fcimb.2023.1167827. eCollection 2023.
5
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.2019 年冠状病毒病中肠道微生物组的改变及其治疗潜力。
World J Gastroenterol. 2022 Dec 21;28(47):6689-6701. doi: 10.3748/wjg.v28.i47.6689.
6
Microbiota Modulation of the Gut-Lung Axis in COVID-19.肠道菌群对 COVID-19 的肺肠轴的调节。
Front Immunol. 2021 Feb 24;12:635471. doi: 10.3389/fimmu.2021.635471. eCollection 2021.
7
Gut microbiota and Covid-19- possible link and implications.肠道微生物群与新冠病毒(COVID-19):可能的联系及影响。
Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13.
8
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.新冠病毒中的肠道微生物群:关键的微生物变化、潜在机制和临床应用。
Nat Rev Gastroenterol Hepatol. 2023 May;20(5):323-337. doi: 10.1038/s41575-022-00698-4. Epub 2022 Oct 21.
9
From the Role of Microbiota in Gut-Lung Axis to SARS-CoV-2 Pathogenesis.从肠道菌群在肺肠轴中的作用到 SARS-CoV-2 的发病机制。
Mediators Inflamm. 2021 Apr 16;2021:6611222. doi: 10.1155/2021/6611222. eCollection 2021.
10
Gut microbiota and COVID-19: A systematic review.肠道微生物群与2019冠状病毒病:一项系统综述。
Health Sci Rep. 2023 Jan 27;6(2):e1080. doi: 10.1002/hsr2.1080. eCollection 2023 Feb.

引用本文的文献

1
COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.《COVID-19组学报告:从个体组学方法到精准医学》
Reports (MDPI). 2023 Sep 22;6(4):45. doi: 10.3390/reports6040045.
2
Gut Microbiota and COVID-19: Unraveling the Gut-Lung Axis and Immunomodulatory Therapies.肠道微生物群与2019冠状病毒病:揭示肠-肺轴与免疫调节疗法
ACS Infect Dis. 2025 Jul 11;11(7):1844-1853. doi: 10.1021/acsinfecdis.5c00250. Epub 2025 Jun 5.
3
Study protocol for a randomised controlled trial evaluating the efficacy of dietary modulation of probiotics on nutritional status and antibody response to SARS-CoV-2 in Indonesian adolescents: gut-lung axis (DIVINE).

本文引用的文献

1
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.描绘 COVID-19 患者中 SARS-CoV-2 粪便病毒活性与肠道微生物群落组成的关系。
Gut. 2021 Feb;70(2):276-284. doi: 10.1136/gutjnl-2020-322294. Epub 2020 Jul 20.
2
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.2019 年冠状病毒病或 H1N1 流感患者肠道微生物组的改变。
Clin Infect Dis. 2020 Dec 17;71(10):2669-2678. doi: 10.1093/cid/ciaa709.
3
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
一项评估益生菌饮食调节对印度尼西亚青少年营养状况和对SARS-CoV-2抗体反应的疗效的随机对照试验研究方案:肠-肺轴(DIVINE)
BMJ Open. 2025 Apr 2;15(4):e087934. doi: 10.1136/bmjopen-2024-087934.
4
Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support.探索 COVID-19 与肠道健康的相互作用:益生元和益生菌在免疫支持中的潜在作用。
Viruses. 2024 Feb 27;16(3):370. doi: 10.3390/v16030370.
5
Association Between Altered Microbiota Composition and Immune System-Related Genes in COVID-19 Infection.新型冠状病毒肺炎感染中微生物群组成改变与免疫系统相关基因之间的关联
Mol Biotechnol. 2025 Mar;67(3):957-973. doi: 10.1007/s12033-024-01096-8. Epub 2024 Mar 8.
6
Post-COVID-19 enterocolitis - a cause of rebellious diarrhea, acute abdomen and liver failure.新冠后肠炎——腹泻难愈、急腹症和肝衰竭的病因。
Rom J Morphol Embryol. 2023 Oct-Dec;64(4):527-533. doi: 10.47162/RJME.64.4.09.
7
Development and management of gastrointestinal symptoms in long-term COVID-19.长期新冠患者胃肠道症状的发展与管理
Front Microbiol. 2023 Dec 14;14:1278479. doi: 10.3389/fmicb.2023.1278479. eCollection 2023.
8
Gut Microbiota Dysbiosis in COVID-19: Modulation and Approaches for Prevention and Therapy.新冠病毒感染中的肠道微生物群失调:调节以及预防和治疗方法
Int J Mol Sci. 2023 Jul 31;24(15):12249. doi: 10.3390/ijms241512249.
9
SARS-CoV-2 and gastrointestinal diseases.严重急性呼吸综合征冠状病毒2与胃肠道疾病。
Front Microbiol. 2023 May 30;14:1177741. doi: 10.3389/fmicb.2023.1177741. eCollection 2023.
10
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways.COVID-19导致肠道微生物群失调的机制:基于不良结局途径的当前证据与不确定性
J Clin Med. 2022 Sep 14;11(18):5400. doi: 10.3390/jcm11185400.
COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
4
Gut microbiota and Covid-19- possible link and implications.肠道微生物群与新冠病毒(COVID-19):可能的联系及影响。
Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13.
5
Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of , the Receptor for SARS-CoV-2 Infectivity.无菌大鼠揭示肠道微生物群可调节SARS-CoV-2感染性受体的结肠mRNA。
Hypertension. 2020 Jul;76(1):e1-e3. doi: 10.1161/HYPERTENSIONAHA.120.15360. Epub 2020 May 19.
6
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.针对 SARS-CoV-2 的免疫反应和 COVID-19 中免疫病理变化的机制。
Allergy. 2020 Jul;75(7):1564-1581. doi: 10.1111/all.14364.
7
[Management of COVID-19: the Zhejiang experience].[新型冠状病毒肺炎的管理:浙江经验]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(2):147-157. doi: 10.3785/j.issn.1008-9292.2020.02.02.
8
Probiotics and COVID-19: one size does not fit all.益生菌与新冠病毒:并非一概而论。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):644-645. doi: 10.1016/S2468-1253(20)30122-9. Epub 2020 Apr 25.
9
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征:一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
10
COVID-19 and the gastrointestinal tract: more than meets the eye.新型冠状病毒肺炎与胃肠道:远不止表面所见。
Gut. 2020 Jun;69(6):973-974. doi: 10.1136/gutjnl-2020-321195. Epub 2020 Apr 9.